Explore more publications!
Guinea Bissau Health Bulletin
Got News to Share?

Guinea Bissau Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 20, 2025

Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion
October 20, 2025

Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion

Indeterminate GlobeNewswire
Oncotelic to Present at the LD Micro Main Event XIX
October 20, 2025

Oncotelic to Present at the LD Micro Main Event XIX

Indeterminate GlobeNewswire
RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria
October 20, 2025

RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria

Indeterminate GlobeNewswire
Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders
October 20, 2025

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

Indeterminate GlobeNewswire
SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
October 20, 2025

SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders

Indeterminate GlobeNewswire
BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025
October 20, 2025

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Indeterminate GlobeNewswire
Press Release: Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program
October 20, 2025

Press Release: Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program

Indeterminate GlobeNewswire
Communiqué de presse : L’autorisation de Sanofi pour Tzield a été acceptée aux États-Unis pour le diabète de type 1 de stade 3 dans le cadre du programme pilote du voucher national de priorité du Commissaire de la FDA
October 20, 2025

Communiqué de presse : L’autorisation de Sanofi pour Tzield a été acceptée aux États-Unis pour le diabète de type 1 de stade 3 dans le cadre du programme pilote du voucher national de priorité du Commissaire de la FDA

Indeterminate GlobeNewswire
Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan
October 20, 2025

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Indeterminate GlobeNewswire
ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025
October 20, 2025

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025

Indeterminate GlobeNewswire
Altimmune to Present Phase 2b IMPACT Data on Pemvidutide in MASH in Late-Breaking Oral Podium Presentation and Late-Breaking Poster at AASLD The Liver Meeting® 2025
October 20, 2025

Altimmune to Present Phase 2b IMPACT Data on Pemvidutide in MASH in Late-Breaking Oral Podium Presentation and Late-Breaking Poster at AASLD The Liver Meeting® 2025

Indeterminate GlobeNewswire
CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance
October 20, 2025

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

Indeterminate GlobeNewswire
OGRD Alliance Expands OncoVix and PLPC-DB Initiatives from the Emirates to Asia and MENA Regions
October 20, 2025

OGRD Alliance Expands OncoVix and PLPC-DB Initiatives from the Emirates to Asia and MENA Regions

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Launches Its Sixth 2025 Spider Silk Production Cycle, Introducing the Next Evolution of Its BAM-1 Alpha Recombinant Silk Platform
October 20, 2025

Kraig Biocraft Laboratories Launches Its Sixth 2025 Spider Silk Production Cycle, Introducing the Next Evolution of Its BAM-1 Alpha Recombinant Silk Platform

Indeterminate GlobeNewswire
Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt
October 20, 2025

Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt

Indeterminate GlobeNewswire
Humber River Health Celebrates 10-Year Anniversary of Wilson Site
October 20, 2025

Humber River Health Celebrates 10-Year Anniversary of Wilson Site

Indeterminate GlobeNewswire
New One-Year Data Reinforcing the Robust and Sustained Efficacy of EMPAVELI® (pegcetacoplan) in C3G and Primary IC-MPGN to be Presented at ASN Kidney Week
October 20, 2025

New One-Year Data Reinforcing the Robust and Sustained Efficacy of EMPAVELI® (pegcetacoplan) in C3G and Primary IC-MPGN to be Presented at ASN Kidney Week

Indeterminate GlobeNewswire
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
October 20, 2025

Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma

Indeterminate GlobeNewswire
Medicenna Therapeutics Announces Participation in Upcoming Conferences
October 20, 2025

Medicenna Therapeutics Announces Participation in Upcoming Conferences

Indeterminate GlobeNewswire
J-Star Applauds the Cooperation of Nasdaq and Ho Chi Minh City to Develop an International Financial Center in Vietnam
October 20, 2025

J-Star Applauds the Cooperation of Nasdaq and Ho Chi Minh City to Develop an International Financial Center in Vietnam

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions